Technical Analysis for TLPH - Talphera, Inc.

Grade Last Price % Change Price Change
C 0.92 -1.97% -0.02
TLPH closed down 1.97 percent on Friday, November 1, 2024, on 34 percent of normal volume. It was able to find support at its 50 day moving average.
Earnings due: Nov 6
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Support Bullish -1.97%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.97%
Wide Bands Range Expansion -1.97%
200 DMA Resistance Bearish -0.02%
Outside Day Range Expansion -0.02%
Wide Bands Range Expansion -0.02%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
20 DMA Support 1 day ago
50 DMA Support 1 day ago
Down 3% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe. This release is intended for investors only
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Pharmaceutical Medication Medical Equipment FDA Syringe Drug Paraphernalia Innovative Therapies Phenylephrine Investigational Device Exemption

Is TLPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.61
52 Week Low 0.425
Average Volume 101,832
200-Day Moving Average 1.00
50-Day Moving Average 0.91
20-Day Moving Average 0.91
10-Day Moving Average 0.96
Average True Range 0.09
RSI (14) 49.75
ADX 21.37
+DI 19.45
-DI 16.14
Chandelier Exit (Long, 3 ATRs) 0.94
Chandelier Exit (Short, 3 ATRs) 0.98
Upper Bollinger Bands 1.14
Lower Bollinger Band 0.69
Percent B (%b) 0.52
BandWidth 49.00
MACD Line 0.02
MACD Signal Line 0.02
MACD Histogram -0.0018
Fundamentals Value
Market Cap 15.6 Million
Num Shares 17 Million
EPS
Price-to-Sales 50.40
Price-to-Book 0.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.99
Resistance 3 (R3) 0.99 0.97 0.98
Resistance 2 (R2) 0.97 0.95 0.97 0.97
Resistance 1 (R1) 0.94 0.94 0.93 0.94 0.97
Pivot Point 0.92 0.92 0.92 0.92 0.92
Support 1 (S1) 0.90 0.90 0.89 0.90 0.87
Support 2 (S2) 0.88 0.89 0.88 0.87
Support 3 (S3) 0.85 0.88 0.86
Support 4 (S4) 0.85